Literature DB >> 6237916

Controlled comparison of the pharmacodynamic effects of nicorandil (SG-75) and isosorbide dinitrate in man.

G G Belz, J Matthews, J Heinrich, G Wagner.   

Abstract

Nicorandil (SG-75) is a long acting mononitrate. A randomized, double-blind, crossover study in 10 healthy subjects has compared the haemodynamic actions of single sublingual doses of nicorandil 15, 30 and 60 mg with Isosorbide dinitrate (ISDN) 5 mg and placebo. Heart rate, blood pressure, systolic time intervals (STI) and left ventricular echocardiograms were used to assess haemodynamics over a 6 h period. Within 15 min of nicorandil administration, heart rate increased and peripheral resistance decreased (dose-dependent); the preejection period (corrected; PEPc) and the ratio of PEP to left ventricular ejection time (LVET) - PEP/LVET - were shortened by the 60 mg dose; the heart rate corrected electromechanical systole (QS2c) was almost unchanged; left ventricular end diastolic and systolic diameters (EDD and ESD) were diminished. The effects on certain parameters had not completely disappeared after 6 h. ISDN produced a similar pattern with somewhat less intense effects; although PEPc and PEP/LVET were prolonged. The effects of both drugs can be attributed to vasodilatation on both the arteriolar and venous sides. The predominant action of ISDN was to reduce preload and thereby to lengthen PEPc and PEP/LVET; in addition, it lessened afterload. Although nicorandil caused a distinct reduction in preload, as shown by the smaller EDD, the effects of afterload reduction were predominant at the high dose induced shortening of PEPc and PEP/LVET. The profile of action of nicorandil should encourage clinical testing to evaluate its ability to induce ventricular unloading.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6237916     DOI: 10.1007/bf00541925

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Systematic correlation of cardiac chamber size and ventricular performance determined with echocardiography and alterations in heart rate in normal persons.

Authors:  A N DeMaria; A Neumann; P J Schubart; G Lee; D T Mason
Journal:  Am J Cardiol       Date:  1979-01       Impact factor: 2.778

2.  [A study to the analysis of systolic time intervals (author's transl)].

Authors:  R Erbel; G G Belz
Journal:  Z Kardiol       Date:  1977-08

3.  Effect of digitalis on systolic time intervals in heart failure.

Authors:  A M Weissler; C D Schoenfeld
Journal:  Am J Med Sci       Date:  1970-01       Impact factor: 2.378

4.  Time course of the effects of single intravenous doses of digitoxin and digoxin in normal volunteers.

Authors:  G G Belz; P E Aust; B Schneider
Journal:  J Cardiovasc Pharmacol       Date:  1981 Sep-Oct       Impact factor: 3.105

5.  Correlation between changes in systolic time intervals and left ventricular end-diastolic diameter after preload reduction. Non-invasive monitoring of pharmacological intervention.

Authors:  J Buch; H Egeblad; P B Hansen; H Kjaergård; S Waldorff; E Steiness
Journal:  Br Heart J       Date:  1980-12

6.  Cardiovascular effects of a new coronary vasodilator N-(2-hydroxyethyl)nicotinamide nitrate (SG-75): comparison with nitroglycerin and diltiazem.

Authors:  K Sakai; Y Shiraki; H Nabata
Journal:  J Cardiovasc Pharmacol       Date:  1981 Jan-Feb       Impact factor: 3.105

7.  Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75).

Authors:  S Holzmann
Journal:  J Cardiovasc Pharmacol       Date:  1983 May-Jun       Impact factor: 3.105

8.  Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.

Authors:  K Chatterjee; W W Parmley
Journal:  J Am Coll Cardiol       Date:  1983-01       Impact factor: 24.094

9.  Relationship between relaxation and cyclic GMP formation caused by nicorandil in canine mesenteric artery.

Authors:  M Endoh; N Taira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-05       Impact factor: 3.000

10.  [Efficacy of nicorandil (SG-75), a substance with nitro-properties and long-term effects in coronary patients: improvement of LV-function and wall motility without pacing-induced myocardial ischemia].

Authors:  J Thormann; M Schlepper; W Kramer; M Gottwik
Journal:  Z Kardiol       Date:  1982-11
View more
  14 in total

1.  Agreement and reproducibility of the estimates of cardiovascular function by impedance cardiography and M-mode echocardiography in healthy subjects.

Authors:  C de Mey; J Matthews; R Butzer; V Schroeter; G G Belz
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

Review 2.  Potassium channel openers. Pharmacological effects and future uses.

Authors:  S Duty; A H Weston
Journal:  Drugs       Date:  1990-12       Impact factor: 9.546

Review 3.  Electrophysiologic effects of potassium channel openers.

Authors:  W Haverkamp; M Borggrefe; G Breithardt
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

4.  Nicorandil-induced changes in the distribution of cardiac output and coronary blood flow in pigs.

Authors:  P D Verdouw; L M Sassen; D J Duncker; I O Schmeets; R J Rensen; P R Saxena
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-09       Impact factor: 3.000

5.  Influence and interference of isosorbide dinitrate and food intake on superior mesenteric artery impedance in humans.

Authors:  D Voet; S Mareels; M Afschrift; M De Buyzere; E Rietzschel; D Duprez
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

Review 6.  Pharmacology and therapeutic effects of nicorandil.

Authors:  M Kinoshita; K Sakai
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

7.  Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography.

Authors:  J Yamazaki; H Ohsawa; T Uchi; M Iida; H Nakano; H Hosoi; T Morishita; Y Yabe; N Koyama; H Komatsu
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris.

Authors:  S Di Somma; V Liguori; M Petitto; A Carotenuto; D Bokor; O de Divitiis; M de Divitiis
Journal:  Cardiovasc Drugs Ther       Date:  1993-02       Impact factor: 3.727

9.  Pharmacokinetics of nicorandil in patients with normal and impaired renal function.

Authors:  M Molinaro; G Villa; M B Regazzi; A Salvadeo; S Segagni; R Rondanelli; E Sartirana
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

10.  The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteers.

Authors:  D L Wolf; J J Ferry; A E Hearron; M O Froeschke; J R Luderer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.